Hudock, Inc. Bristol Myers Squibb CO Transaction History
Hudock, Inc.
- $571 Million
- Q1 2025
A detailed history of Hudock, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hudock, Inc. holds 5,407 shares of BMY stock, worth $270,187. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,407
Previous 5,462
1.01%
Holding current value
$270,187
Previous $308,000
6.82%
% of portfolio
0.06%
Previous 0.05%
Shares
32 transactions
Others Institutions Holding BMY
# of Institutions
2,811Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.56 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.93 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.4 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.74 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.32 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...